Xgeva

INFORMATION FOR ADULT XGEVA® (denosumab) PATIENTS

This site is designed for adult patients who have been prescribed XGEVA® (denosumab). XGEVA® is a single subcutaneous injection given in the thigh, abdomen or upper arm every four weeks.
Your healthcare professional may give you the option to administer your XGEVA® (denosumab) at home through self-administration or from the support of a carer, friend or relative. Please see below some materials to support with home administration of XGEVA® (denosumab). Unless you have been instructed by your advising health care professional do not try to give yourself the injection.
Should you have any concerns or questions regarding your treatment with XGEVA®, please speak to your doctor/nurse. For information on side effects and how to report them please click the ‘Report side effects’ tab above.

Patient Guide: Treatment with XGEVA® (denosumab) for the prevention of complications from bone metastases

This guide is for adult patients prescribed XGEVA® to provide more information about your treatment. It covers topics such as what XGEVA® (denosumab) is used for, safety information as well as information that you need to be aware of before and during your treatment with XGEVA®. Click the button below to download a PDF version of the booklet.

Home administration of XGEVA® (denosumab) by self/carers

The following documents are provided to help support you or your carer/relative in the home administration of XGEVA®. The written and video guides provide step-by-step instructions for adult patients on the preparation and administration of XGEVA® - and demonstrate how, with practise, self/carer administration can become a routine part of your life.
Click on the image below to access the video and beneath find the written guide available to download
Unless you have been instructed by your advising health care professional do not try to give yourself the injection.
These materials have been developed by Amgen to support the NHS with home administration of XGEVA®. They are intended to supplement, but not replace, the guidance of your prescribing health care provider, who should be contacted if you have any questions with regard to denosumab or home administration.
For a list of side effects, please see the patient information leaflet (PIL).